Respiratory disease in the Asia-Pacific region: Cough as a key symptom.

Related Articles

Respiratory disease in the Asia-Pacific region: Cough as a key symptom.

Allergy Asthma Proc. 2016 Jan 21;

Authors: Cho SH, Ghoshal AG, Lin HC, Muttalif AR, Thanaviratananich S, Bagga S, Faruqi R, Sajjan S, Brnabic AJ, Dehle FC, Wang DY

Abstract
BACKGROUND: Respiratory diseases represent a significant impact on health care. A cross-sectional, multicountry (India, Korea, Malaysia, Singapore, Taiwan, and Thailand) observational study was conducted to investigate the proportion of adult patients who received care for a primary diagnosis of asthma, allergic rhinitis (AR), chronic obstructive pulmonary disease (COPD), or rhinosinusitis.
OBJECTIVE: To determine the proportion of patients who received care for asthma, AR, COPD, and rhinosinusitis, and the frequency and main symptoms reported.
METHODS: Patients ages greater than or equal to 18 years, who presented to a physician with symptoms that met the diagnostic criteria for a primary diagnosis of asthma, AR, COPD, or rhinosinusitis were enrolled. Patients and physicians completed a survey that contained questions related to demographics and respiratory symptoms.
RESULTS: A total of 13,902 patients with a respiratory disorder were screened, of whom 7030 were eligible and 5250 enrolled. The highest percentage of patients who received care had a primary diagnosis of AR (14.0% [95% confidence interval {CI}, 13.4 -14.6%]), followed by asthma (13.5% [95% CI, 12.9 -14.1%]), rhinosinusitis (5.4% [95% CI, 4.6 -5.3%]), and COPD (4.9% [95% CI, 5.0 -5.7%]). Patients with a primary diagnosis of COPD (73%), followed by asthma (61%), rhinosinusitis (59%), and AR (47%) most frequently reported cough as a symptom. Cough was the main reason for seeking medical care among patients with a primary diagnosis of COPD (43%), asthma (33%), rhinosinusitis (13%), and AR (11%).
CONCLUSION: Asthma, AR, COPD, and rhinosinusitis represent a significant proportion of respiratory disorders in patients who presented to health care professionals in the Asia-Pacific region, many with concomitant disease. Cough was a prominent symptom and the major reason for patients with respiratory diseases to seek medical care.

PMID: 26802834 [PubMed – as supplied by publisher]

View full post on pubmed: asthma

Beliefs about medication predict the misattribution of a common symptom as a medication side effect – Evidence from an analogue online study.

Related Articles

Beliefs about medication predict the misattribution of a common symptom as a medication side effect – Evidence from an analogue online study.

J Psychosom Res. 2015 Oct 13;

Authors: Heller MK, Chapman SC, Horne R

Abstract
OBJECTIVE: Some perceived medication side effects may be ‘normal’ symptoms that patients misattribute to the medication. Using an analogue approach, we tested if medication beliefs predict whether participants misattribute a headache as a side effect and subsequently intend to stop medication.
METHODS: We recruited 690 participants, 223 reporting a past asthma diagnosis. They received information about asthma and Molair, a fictitious asthma treatment modeled on a licensed treatment (montelukast). We varied the description of efficacy and side effects (which did not include headache). Pre-exposure to this information, participants completed the Beliefs about Medicine Questionnaire (BMQ)-General and the Perceived Sensitivity to Medicines Scale (PSM), post-exposure they completed the BMQ-Specific. Participants were asked to imagine they experienced a headache while taking Molair. Finally, they rated whether the headache was a side effect (misattribution) and if they would stop taking Molair (behavioral intention).
RESULTS: Nearly a quarter (170) of participants misattributed the headache to Molair and 69 (10%) subsequently intended to stop Molair. Both outcomes were predicted by general and specific medication beliefs. Odds of misattribution (m) and behavioral intention (i) increased with higher General Harm (ORm=1.90, ORi=2.72), General Overuse (ORm=1.74, ORi=1.56) and Molair Concern beliefs (ORm=1.52, ORi=1.78, all p<.01), but decreased with General Benefit (ORm=0.72, ORi=0.53) and Molair Necessity beliefs (ORm=0.72, ORi=0.70, all p<.05).
CONCLUSION: Symptom misattribution and subsequent intentions to stop Molair were predicted by pre-exposure beliefs about medicines in general and post-exposure beliefs about Molair. Patients with negative medication beliefs may be prone to misattribute symptoms and subsequently stop medication.

PMID: 26519128 [PubMed – as supplied by publisher]

View full post on pubmed: asthma

Asthma study could help kids live symptom free – WJXT Jacksonville


WJXT Jacksonville

Asthma study could help kids live symptom free
WJXT Jacksonville
“Perhaps having more of this healthy type of fat that has an anti-inflammatory effect, could it actually help treat asthma and treat the inflammation with asthma,” explained Jason Lang, M.D., Pulmonary Pediatrician at Nemours's Children's Hospital in
Foods that Relieve AsthmaWTAJ

all 2 news articles »

View full post on asthma – Google News

Symptom of Respiratory Illness Infecting Midwest Children is Asthma Attacks – CBS Local


CBS Local

Symptom of Respiratory Illness Infecting Midwest Children is Asthma Attacks
CBS Local
“Since the second week of August, we were seeing children admitted to the hospital with asthma attacks,” says Dr. Mary Anne Jackson, the hospital's head of infectious diseases. “What was unusual is a third had no prior history of asthma, and these were …
Denver Hospitals See Spike In Respiratory Virus In KidsWFMY News 2
Midwest's 'Mystery Virus' Is Scary but Not DeadlyDaily Beast

all 29 news articles »

View full post on asthma – Google News